BNP Paribas Financial Markets
RKDA icon

BNP Paribas Financial Markets’s Arcadia Biosciences RKDA Stock Holding History

BNP Paribas Financial Markets’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2
Closed -$5.89K – 3006
2015
Q4 		$5.89K Hold
2
– – ﹤0.01% 3446
2015
Q3 		$5.79K Buy
+2
New +$8.32K ﹤0.01% 3478

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

BNP Paribas Financial Markets's RKDA Position: Q1 2016 in Review

BNP Paribas Financial Markets sold out of Arcadia Biosciences (RKDA) in Q1 2016, closing a stake of 2 shares — an estimated $5.89K sold.

BNP Paribas Financial Markets first reported a position in RKDA in Q3 2015 and held it in 2 quarters. The position peaked at $5.89K in Q4 2015. 25 funds tracked by Wall St. Rank hold RKDA as of Q1 2016.

  • BNP Paribas Financial Markets reported no remaining Arcadia Biosciences position as of Q1 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 Arcadia Biosciences shares in Q1 2016, an estimated $5.89K.
  • BNP Paribas Financial Markets first reported a position in Arcadia Biosciences in Q3 2015 and held it in 2 quarters.
  • BNP Paribas Financial Markets's Arcadia Biosciences position peaked at $5.89K in Q4 2015.
  • 25 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2016, filed 22 Apr 2016.